Tonix Pharmaceuticals Holding Corp. (TNXP)
15.74
+1.65
(+11.71%)
USD |
NASDAQ |
May 15, 16:00
15.50
-0.24
(-1.52%)
After-Hours: 20:00
Tonix Pharmaceuticals EPS Diluted (Quarterly) : -2.932 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.3446 |
| MetaVia, Inc. | -0.7867 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.19M |
| Revenue (Quarterly) | 6.878M |
| Total Expenses (Quarterly) | 47.07M |
| Enterprise Value | -68.38M |
| Gross Profit Margin (Quarterly) | 68.99% |
| Profit Margin (Quarterly) | -584.4% |
| Earnings Yield | -91.20% |
| Normalized Earnings Yield | -91.19 |